Search

Your search keyword '"Merino, Esperanza"' showing total 424 results

Search Constraints

Start Over You searched for: Author "Merino, Esperanza" Remove constraint Author: "Merino, Esperanza"
424 results on '"Merino, Esperanza"'

Search Results

3. Safety and effectiveness of isavuconazole in real-life non-neutropenic patients

5. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

8. How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations

10. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

11. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

14. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

16. An integrated emergency department/hospital at home model in mild COVID-19 pneumonia: feasibility and outcomes after discharge from the emergency department

19. Enhanced recovery after low- and medium-risk liver transplantation. A single-center prospective observational cohort study

20. Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients

21. Comparison of Different Methods for Assaying the In Vitro Activity of Cefiderocol against Carbapenem-Resistant Pseudomonas aeruginosa Strains: Influence of Bacterial Inoculum.

22. Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000-2015

23. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

24. Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients—Results of a Spanish multicenter cohort

25. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

26. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

28. Corrigendum to “Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients” [International Journal of Infectious Diseases 144 (2024) 107070]

29. High delayed mortality after the first episode of Clostridium difficile infection

30. Role of age and comorbidities in mortality of patients with infective endocarditis

31. A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence status

32. Rationale for combined therapies in severe-to-critical COVID-19 patients

33. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

34. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis

35. Infective Endocarditis in Patients With Bicuspid Aortic Valve or Mitral Valve Prolapse

38. Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial

39. Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients

40. Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin

41. Mild SARS-CoV-2 infection in vulnerable patients: implementation of a clinical pathway for early treatment

42. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes

43. Rationale for combined therapies in severe-to-critical COVID-19 patients

44. Transient changes in the plasma of astrocytic and neuronal injury biomarkers in COVID-19 patients without neurological syndromes

45. Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin

46. Rationale for combined therapies in severe-to-critical COVID-19 patients

47. Perinatal exposure to pesticides alters synaptica plasticity signaling and induces behavioral deficits associated with neurodevelopment disorders

50. Effectiveness and Safety of a Structured De-Escalation from Antipseudomonal Β-Lactams in Bloodstream Infections Due to Enterobacterales: A Multicentre Randomised Clinical Trial (SIMPLIFY)

Catalog

Books, media, physical & digital resources